Integer Holdings Corp (ITGR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Integer Holdings Corp (ITGR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011023
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Integer Holdings Corp (Integrated Holdings), formerly Greatbatch Inc is a medical device outsource manufacturer that designs and develops medical devices and power solutions for the medical and non-medical markets. The company offers products such as arthroscopic devices and components, laparoscopic and general surgery, biopsy and drug delivery, orthopedic, cardiac rhythm management and neuromodulation; and vascular access products. Its cardiac rhythm management and neuromodulation products comprise batteries, capacitors, catheters, coated electrodes, device headers, device enclosures, battery and capacitors cases; feedthroughs and filtered feedthroughs, leads therapy development components, and accessories. Greatbatch offers orthopedic products such as hip replacements, silicone handles, and delivery systems. The company has operations in the US, Switzerland, Mexico, France, Germany, Ireland, and Uruguay, among others. Greatbatch is headquartered in Frisco, Texas, the US.

Integer Holdings Corp (ITGR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Integer Holdings Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Integer Holdings Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Integer Holdings Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Integer Holdings Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Integer Holdings Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Integer Holdings Corp, Medical Equipment, Deal Details 12
Venture Financing 12
Aleva Neurotherapeutics Raises USD18 Million in Series C Financing Round 12
Aleva Neurotherapeutics to Raise Funds in Series C Financing 14
Cardionomic Raises USD20 Million in Series A Financing Round 15
Partnerships 16
Greatbatch Extends its Licensing Agreement with WiTricity 16
Aleva Neurotherapeutics Enters into Agreement with Greatbatch 17
ECA Medical Instruments Enters Into Distribution Agreement With Greatbatch Medical For Orthopedic Surgical Instruments 18
Boston Scientific Enters Into Partnership With Greatbatch Medical 19
Debt Offering 20
Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023 20
Acquisition 21
Greatbatch Acquires Lake Region Medical for USD1.73 Billion 21
Greatbatch Acquires C.C.C. Del Uruguay for USD18 Million 23
Accellent Completes Acquisition Of Lake Region Medical, Manufacturer Of Medical Devices 24
Greatbatch Acquires NeuroNexus Technologies, Neurotechnology Company 26
Boston Scientific Acquires Remaining Stake In Intelect Medical For US$60 Million 27
Integer Holdings Corp – Key Competitors 28
Integer Holdings Corp – Key Employees 29
Integer Holdings Corp – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 32
Financial Announcements 32
Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results 32
Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results 34
May 08, 2017: Integer Holdings Reports First Quarter 2017 Results 35
Feb 27, 2017: Integer Holdings Reports Results for Fourth Quarter and Full Year 2016 36
Jul 28, 2016: Integer Holdings Reports 2016 Second Quarter Results 39
Apr 28, 2016: Greatbatch Reports 2016 First Quarter Results 42
Feb 29, 2016: Greatbatch Reports 2015 Fourth Quarter and Full Year Results 44
Jan 11, 2016: Greatbatch Provides Preliminary 2015 Revenue Results and 2016 Guidance 47
Corporate Communications 48
Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 48
Mar 27, 2017: Integer Announces Leadership Change 49
Feb 27, 2017: Gary Haire to Join Integer as Executive Vice President and Chief Financial Officer 50
Legal and Regulatory 51
Jun 27, 2016: Greatbatch Renamed Integer Holdings 51
Other Significant Developments 52
Jan 26, 2016: Greatbatch Awarded $37.5 Million in Patent Infringement Lawsuit Against AVX 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Integer Holdings Corp, Medical Equipment, Key Facts, 2016 2
Integer Holdings Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Integer Holdings Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Integer Holdings Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Integer Holdings Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Integer Holdings Corp, Deals By Market, 2011 to YTD 2017 9
Integer Holdings Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Aleva Neurotherapeutics Raises USD18 Million in Series C Financing Round 12
Aleva Neurotherapeutics to Raise Funds in Series C Financing 14
Cardionomic Raises USD20 Million in Series A Financing Round 15
Greatbatch Extends its Licensing Agreement with WiTricity 16
Aleva Neurotherapeutics Enters into Agreement with Greatbatch 17
ECA Medical Instruments Enters Into Distribution Agreement With Greatbatch Medical For Orthopedic Surgical Instruments 18
Boston Scientific Enters Into Partnership With Greatbatch Medical 19
Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023 20
Greatbatch Acquires Lake Region Medical for USD1.73 Billion 21
Greatbatch Acquires C.C.C. Del Uruguay for USD18 Million 23
Accellent Completes Acquisition Of Lake Region Medical, Manufacturer Of Medical Devices 24
Greatbatch Acquires NeuroNexus Technologies, Neurotechnology Company 26
Boston Scientific Acquires Remaining Stake In Intelect Medical For US$60 Million 27
Integer Holdings Corp, Key Competitors 28
Integer Holdings Corp, Key Employees 29
Integer Holdings Corp, Subsidiaries 30

★海外企業調査レポート[Integer Holdings Corp (ITGR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cerus Corp (CERS):医療機器:M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Taubman Centers Inc (TCO):企業の財務・戦略的SWOT分析
    Taubman Centers Inc (TCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Integrated BioPharma Inc (INBP):企業の財務・戦略的SWOT分析
    Summary Integrated BioPharma Inc (IBI) is a biopharmaceutical company that develops, manufactures and distributes vitamins, nutritional supplements and herbal products. The company’s contract business includes manufacturing, branded proprietary products, and other nutraceutical businesses. Its contr …
  • Celgene Corporation:企業のM&A・事業提携・投資動向
    Celgene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celgene Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • KPC Pharmaceuticals Inc (600422):製薬・医療:M&Aディール及び事業提携情報
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and special botanical drugs. It also offers drugs suc …
  • Otto Bock HealthCare GmbH:企業の戦略的SWOT分析
    Otto Bock HealthCare GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mitsubishi Estate Co., Ltd.:企業の戦略・SWOT・財務情報
    Mitsubishi Estate Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Estate Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Acceleron Pharma Inc (XLRN):企業の財務・戦略的SWOT分析
    Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive informat …
  • Mercer International Inc (MERC):企業の財務・戦略的SWOT分析
    Mercer International Inc (MERC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Huber+Suhner AG (HUBN):企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • DBV Technologies SA (DBV):企業の財務・戦略的SWOT分析
    Summary DBV Technologies SA (DBV) is a biopharmaceutical company that develops products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets non-invasive epicutaneous delivery technology and products for healthcare markets. Its viaskin technology platform …
  • PerkinElmer Inc (PKI):企業の製品パイプライン分析
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services. The company’s major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography …
  • Arizona State University-製薬・医療分野:企業M&A・提携分析
    Summary Arizona State University (ASU) is an educational and research university that provides entrepreneurship solutions. The university’s services include academic services, knowledge enterprise development, institutes and initiative consulting, industry engagement, entrepreneurship, support and c …
  • Amphastar Pharmaceuticals Inc (AMPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. The company’s product …
  • U.S. Energy Corp (USEG):企業の財務・戦略的SWOT分析
    Summary U.S. Energy Corp (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas properties. The company provides maintenance of mineral properties. It operates its oil and gas prospects located in the Williston Basin of North Dakota, the Eagl …
  • FSONA Networks Corp.:企業の戦略的SWOT分析
    FSONA Networks Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Eldorado Gold Corporation:企業の戦略・SWOT・財務情報
    Eldorado Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Eldorado Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Vermillion Inc (VRML):企業の財務・戦略的SWOT分析
    Summary Vermillion Inc (Vermillion) is a medical device company that discovers, develops and markets diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve gynecologic health outcomes for women. The company’s in vitro diagnostic test OVA1, a simple blood test …
  • Young’s Market Co LLC:企業の戦略的SWOT分析
    Young's Market Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆